210 related articles for article (PubMed ID: 17328085)
1. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study.
Li C; Hu Z; Liu Z; Wang LE; Gershenwald JE; Lee JE; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer; 2007 Apr; 109(8):1570-8. PubMed ID: 17328085
[TBL] [Abstract][Full Text] [Related]
2. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.
Gałecki P; Maes M; Florkowski A; Lewiński A; Gałecka E; Bieńkiewicz M; Szemraj J
J Affect Disord; 2011 Mar; 129(1-3):175-82. PubMed ID: 20888049
[TBL] [Abstract][Full Text] [Related]
3. Association between achalasia and nitric oxide synthase gene polymorphisms.
Mearin F; García-González MA; Strunk M; Zárate N; Malagelada JR; Lanas A
Am J Gastroenterol; 2006 Sep; 101(9):1979-84. PubMed ID: 16848803
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in neuronal nitric oxide synthase (nNOS) gene and susceptibility to cerebral malaria in Indian adults.
Dhangadamajhi G; Mohapatra BN; Kar SK; Ranjit M
Infect Genet Evol; 2009 Sep; 9(5):908-11. PubMed ID: 19540363
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase gene polymorphisms in children with primary nocturnal enuresis: a preliminary study.
Balat A; Alasehirli B; Oguzkan S; Gungor M
Ren Fail; 2007; 29(1):79-83. PubMed ID: 17365914
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in Korean population.
Lee TS; Jeon YT; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():134-42. PubMed ID: 17404026
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases.
Holla LI; Stejskalova A; Znojil V; Vasku A
Clin Exp Allergy; 2006 Dec; 36(12):1592-601. PubMed ID: 17177683
[TBL] [Abstract][Full Text] [Related]
13. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
15. Neuronal and inducible nitric oxide synthase expression in the rat cerebellum following portacaval anastomosis.
Suárez I; Bodega G; Rubio M; Felipo V; Fernández B
Brain Res; 2005 Jun; 1047(2):205-13. PubMed ID: 15904901
[TBL] [Abstract][Full Text] [Related]
16. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
17. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome.
Winkelmann J; Lichtner P; Schormair B; Uhr M; Hauk S; Stiasny-Kolster K; Trenkwalder C; Paulus W; Peglau I; Eisensehr I; Illig T; Wichmann HE; Pfister H; Golic J; Bettecken T; Pütz B; Holsboer F; Meitinger T; Müller-Myhsok B
Mov Disord; 2008 Feb; 23(3):350-8. PubMed ID: 18058820
[TBL] [Abstract][Full Text] [Related]
18. A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans.
Gu J; Wu X; Dong Q; Romeo MJ; Lin X; Gutkind JS; Berman DM
Cancer; 2006 Jun; 106(12):2716-24. PubMed ID: 16691626
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility.
Ibarrola-Villava M; Peña-Chilet M; Fernandez LP; Aviles JA; Mayor M; Martin-Gonzalez M; Gomez-Fernandez C; Casado B; Lazaro P; Lluch A; Benitez J; Lozoya R; Boldo E; Pizarro A; Martinez-Cadenas C; Ribas G
Eur J Cancer; 2011 Nov; 47(17):2618-25. PubMed ID: 21641795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
